Okomera announces Bpifrance funding to develop and standardize novel CRISPR screening assay to accelerate drug discovery in oncology with leading cancer research center of Marseille, CRCM. Okomera is ...
Okomera announces Bpifrance funding to develop and standardize novel CRISPR screening assay to accelerate drug discovery in ...
The mRNA Revolution When the COVID-19 pandemic struck, the world's medical community initially prepared for a disaster of the scale of the Spanish Flu, which struck during WW1 and killed 50 million ...
BioNTech (BNTX) and OncoC4 have had a partial clinical hold placed by the FDA on a Phase 3 study for BNT316/ONC-392 in the ...
Zacks.com on MSN2d
ILMN Stock Trading Near 52-Week High: Should You Buy, Sell or Hold?Shares of Illumina ILMN have been showcasing impressive market performance, reaching a new 52-week-high of $151.04 during Tuesday’s trading session. The stock finished at $143.52 yesterday, just 5.2% ...
SILER CITY, N.C. (WTVD) -- The Biden-Harris administration announced plans Tuesday to provide up to $750 million in direct funding to Wolfspeed, with the money supporting its new silicon carbide ...
NANTES, France, October 17, 6:00pm CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), today announced it will be presenting its ...
The global high potency API (HPAPI) contract manufacturing market achieved a market value of USD 8 billion in 2022 and is ...
Singlera Genomics is in the process of launching a clinical trial to obtain FDA pre-market approval for the PDACatch assay in the US, as well as obtaining EU certification for the assay. Singlera ...
Diakonos’ dendritic cell vaccine represents a unique approach for engaging an immune response against a patient’s cancer.
We recently compiled a list of 10 High Growth NASDAQ Stocks That Are Profitable in 2024. In this article, we will look at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback